HSBC vs WFC

HSBC presents a contradictory profile, anchored by a weak Piotroski F-Score of 2/9 which indicates significant fundamental health concerns. While the stock shows explosive YoY revenue and earnings growth, this is offset by a poor earnings track record with an average surprise of -52.96% and a bearish technical trend (10/100). There is a massive valuation gap between the Graham Number ($41.8) and the growth-based Intrinsic Value ($177.0), suggesting the current price of $89.96 is speculative. Despite these risks, the dividend profile remains stable and the forward P/E is attractive.

WFC presents a stark contrast between poor deterministic health and strong valuation/growth metrics. The Piotroski F-Score of 2/9 indicates weak financial health, which heavily penalizes the fundamental baseline. However, the stock is trading almost exactly at its Graham Number ($86.56), suggesting it is fairly valued defensively, while its intrinsic value ($166.83) suggests significant long-term upside. Steady earnings growth of 13.1% YoY and a sustainable payout ratio provide a buffer against the bearish insider sentiment and weak health scores.